| Day-night dip and early-morning surge in blood pressure in hypertension: prognostic implications P Verdecchia, F Angeli, G Mazzotta, M Garofoli, E Ramundo, G Gentile, ... Hypertension 60 (1), 34-42, 2012 | 365 | 2012 |
| The renin angiotensin system in the development of cardiovascular disease: role of aliskiren in risk reduction P Verdecchia, F Angeli, G Mazzotta, G Gentile, G Reboldi Vascular health and risk management 4 (5), 971-981, 2008 | 136 | 2008 |
| Influence of blood pressure reduction on composite cardiovascular endpoints in clinical trials P Verdecchia, G Gentile, F Angeli, G Mazzotta, G Mancia, G Reboldi Journal of hypertension 28 (7), 1356-1365, 2010 | 96 | 2010 |
| Atrial fibrillation and mortality in patients with acute myocardial infarction: a systematic overview and meta-analysis F Angeli, G Reboldi, M Garofoli, E Ramundo, C Poltronieri, G Mazzotta, ... Current cardiology reports 14, 601-610, 2012 | 94 | 2012 |
| Home blood pressure measurements will not replace 24-hour ambulatory blood pressure monitoring P Verdecchia, F Angeli, G Mazzotta, G Gentile, G Reboldi Hypertension 54 (2), 188-195, 2009 | 78 | 2009 |
| The voltage of R wave in lead aVL improves risk stratification in hypertensive patients without ECG left ventricular hypertrophy P Verdecchia, F Angeli, C Cavallini, G Mazzotta, S Repaci, S Pede, ... Journal of hypertension 27 (8), 1697-1704, 2009 | 78 | 2009 |
| New-onset hyperglycemia and acute coronary syndrome: a systematic overview and meta-analysis F Angeli, P Verdecchia, G Karthikeyan, G Mazzotta, M Pinto, S Repaci, ... Current diabetes reviews 6 (2), 102-110, 2010 | 77 | 2010 |
| β-Blockers reduce mortality in patients undergoing high-risk non-cardiac surgery F Angeli, P Verdecchia, G Karthikeyan, G Mazzotta, G Gentile, G Reboldi American journal of cardiovascular drugs 10, 247-259, 2010 | 68 | 2010 |
| Aggressive blood pressure lowering is dangerous: the J-curve: con side of the argument P Verdecchia, F Angeli, G Mazzotta, M Garofoli, G Reboldi Hypertension 63 (1), 37-40, 2014 | 63 | 2014 |
| ACE-inhibitors, angiotensin receptor blockers and severe acute respiratory syndrome caused by coronavirus P Verdecchia, G Reboldi, C Cavallini, G Mazzotta, F Angeli Giornale Italiano di Cardiologia (2006) 21 (5), 321-327, 2020 | 41 | 2020 |
| Comparative assessment of angiotensin receptor blockers in different clinical settings P Verdecchia, F Angeli, S Repaci, G Mazzotta, G Gentile, G Reboldi Vascular Health and Risk Management, 939-948, 2009 | 38 | 2009 |
| Statins in acute coronary syndrome: very early initiation and benefits F Angeli, G Reboldi, G Mazzotta, M Garofoli, MF Cerasa, P Verdecchia Therapeutic advances in cardiovascular disease 6 (4), 163-174, 2012 | 35 | 2012 |
| Safety and efficacy of aliskiren in the treatment of hypertension and associated clinical conditions F Angeli, G Reboldi, G Mazzotta, C Poltronieri, M Garofoli, E Ramundo, ... Current Drug Safety 7 (1), 76-85, 2012 | 34 | 2012 |
| Telmisartan for the reduction of cardiovascular morbidity and mortality P Verdecchia, F Angeli, G Gentile, G Mazzotta, G Reboldi Expert review of clinical pharmacology 4 (2), 151-161, 2011 | 34 | 2011 |
| Aliskiren versus ramipril in hypertension P Verdecchia, F Angeli, G Mazzotta, P Martire, M Garofoli, G Gentile, ... Therapeutic advances in cardiovascular disease 4 (3), 193-200, 2010 | 32 | 2010 |
| Fixed-dose combination therapy in hypertension: cons F Angeli, G Reboldi, G Mazzotta, M Garofoli, E Ramundo, C Poltronieri, ... High Blood Pressure & Cardiovascular Prevention 19, 51-54, 2012 | 31 | 2012 |
| Prognostic usefulness of left ventricular hypertrophy by electrocardiography in patients with atrial fibrillation (from the Randomized Evaluation of Long-Term Anticoagulant … P Verdecchia, G Reboldi, G Di Pasquale, G Mazzotta, G Ambrosio, ... The American journal of cardiology 113 (4), 669-675, 2014 | 27 | 2014 |
| Neutrophil count and ambulatory pulse pressure as predictors of cardiovascular adverse events in postmenopausal women with hypertension F Angeli, E Angeli, G Ambrosio, G Mazzotta, C Cavallini, G Reboldi, ... American journal of hypertension 24 (5), 591-598, 2011 | 26 | 2011 |
| Cardiac Biomarkers and Left Ventricular Hypertrophy in Relation to Outcomes in Patients With Atrial Fibrillation: Experiences From the RE‐LY Trial Z Hijazi, P Verdecchia, J Oldgren, U Andersson, G Reboldi, ... Journal of the American Heart Association 8 (2), e010107, 2019 | 22 | 2019 |
| Angiotensin converting enzyme inhibitors and angiotensin receptor blockers in the treatment of hypertension: should they be used together? P Verdecchia, F Angeli, G Mazzotta, G Ambrosio, G Reboldi Current vascular pharmacology 8 (6), 742-746, 2010 | 22 | 2010 |
